289
Participants
Start Date
August 31, 2016
Primary Completion Date
January 26, 2021
Study Completion Date
August 16, 2023
Niraparib
Participants will receive 300 mg niraparib (3 capsules\*100 mg) orally once daily.
Tucson
Los Angeles
Riverside
Sacramento
Aurora
Denver
Evanston
Danville
Louisville
New Orleans
Boston
Detroit
Omaha
New York
Durham
Lancaster
Philadelphia
Myrtle Beach
Houston
Charlottesville
Fairfax
Seattle
Madison
Camperdown
Darlinghurst
East Albury
Kurralta Park
Macquarie University
Melbourne
Murdoch
Port Macquarie
Randwick
Wahroonga
Aalst
Brussels
Charleroi
Ghent
Haine-Saint-Paul
Hasselt
Kortrijk
Liège
Namur
Ottignies
Wilrijk
Barretos
Belo Horizonte
Curitiba
Fortaleza
Ijuí
Itajaí
Joinville
Natal
Salvador
São Paulo
Vancouver
Oshawa
Toronto
Montreal
Québec
Aarhus N
Copenhagen N
Herlev
Odense C
Avignon
Besançon
Caen
Lyon
Nice
Paris
Reims
Strasbourg
Villejuif
Beersheba
Haifa
Kfar Saba
Ramat Gan
Zrifin
Alkmaar
Amsterdam
Groningen
Maastricht
Rotterdam
Moscow
Omsk
Tomsk
Seoul
Barcelona
Córdoba
Madrid
Málaga
Pozuelo de Alarcón
Santander
Santiago de Compostela
Seville
Valencia
Gothenburg
Lund
Stockholm
Umeå
Kaohsiung City
Taichung
Tainan City
Taipei
Taoyuan
Blackburn
Bristol
Cardiff
Exeter
London
Preston
Janssen Research & Development, LLC
INDUSTRY